| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162416 Expression vector for use in transformation and propagation of heterologous nucleotide sequences in eucaryotic cells; bioreactors |
| 08/19/2004 | US20040162260 Drug delivery; to decrease cellular toxicity and improve efficacy |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162256 Method for producing sterile polynucleotide based medicaments |
| 08/19/2004 | US20040162255 To deliver specifically tailored small interfering RNA as therapeutic agents for treatment of Parkinson's disease |
| 08/19/2004 | US20040162254 Antiviral oligonucleotides targeting HSV and CMV |
| 08/19/2004 | US20040162253 Administering pharmacologically acceptable oligonucleotide at least 10 nucleotides in length, wherein the anti-HBV activity of oligonucleotide occurs principally by a non-sequence complementary mode of action |
| 08/19/2004 | US20040162252 Administering formulation capable of inhibiting at least one host cell protein needed for replication of a virus |
| 08/19/2004 | US20040162251 Pharmaceutical composition containing decoy and method of using the same |
| 08/19/2004 | US20040162250 Remedy and preventive for diseases caused by NF-kB |
| 08/19/2004 | US20040162235 Forming a complex of polyampholyte and siRNA; and, delivering the complex into a cell |
| 08/19/2004 | US20040161849 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 08/19/2004 | US20040161848 Adenoviral vector and related system and methods of making and use |
| 08/19/2004 | US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161777 Nucleotide sequences comprising terminal caps and inverted 3'-3' linkage for use in gene expression inhibition and preventing disease |
| 08/19/2004 | US20040161746 Method of testing allergic disease |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161739 HIV diagnostic methods |
| 08/19/2004 | US20040161467 Particulate drug-containing products and method of manufacture |
| 08/19/2004 | US20040161463 Supplying, condensation,forming nucleic acids binding polymers |
| 08/19/2004 | US20040161418 Adeno-associated virus vector for boosting immunogenicity of cells |
| 08/19/2004 | US20040161417 Inhibiting expression of invariant chain protein (li) in antigen presenting cells |
| 08/19/2004 | US20040161416 Delivering DNA sequence imparting sustained rheumatoid arthritis relief |
| 08/19/2004 | US20040161410 Involving nucleotide sequence 15 or 19; efficient, well tolerated |
| 08/19/2004 | CA2814767A1 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | CA2515644A1 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | CA2515123A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515122A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2515000A1 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | CA2514841A1 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | CA2514643A1 Light probe for ultraviolet light activated gene transduction |
| 08/19/2004 | CA2506619A1 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/18/2004 | EP1447450A1 Method of regulating expression of gene carried on viral vector |
| 08/18/2004 | EP1447414A2 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 08/18/2004 | EP1446504A2 Emulsion compositions |
| 08/18/2004 | EP1446501A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446495A2 Whole cell engineering using real-time metabolic flux analysis |
| 08/18/2004 | EP1446489A2 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 08/18/2004 | EP1446479A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 08/18/2004 | EP1446412A2 Novel lna compositions and uses thereof |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446014A2 INTRODUCTION OF THE WLDs GENE FOR PREVENTION OF AXONAL DEGENERATION IN NEUROLOGICAL DISEASES |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1370138A4 Gene therapy for neurological tissues |
| 08/18/2004 | EP1083882A4 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier |
| 08/18/2004 | EP1038025A4 Genetic alterations associated with cancer |
| 08/18/2004 | EP0946744B1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes |
| 08/18/2004 | EP0928135A4 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 08/18/2004 | EP0881914B1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/18/2004 | EP0877622B1 Method of inactivation of ras subfamily proteins and agents therefor |
| 08/18/2004 | EP0871730B1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 08/18/2004 | EP0835137B1 Encapsulated cells producing viral particles |
| 08/18/2004 | EP0833920B1 Transferrin receptor genes |
| 08/18/2004 | EP0817851B9 Dna encoding human papilloma virus type 18 |
| 08/18/2004 | CN1522300A Novel maxizyme |
| 08/18/2004 | CN1522160A Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 08/18/2004 | CN1522153A Novel composition |
| 08/18/2004 | CN1162547C Hepatitis B virus antisense RNA expression vector targeting liver cancer and its construction process and use |
| 08/18/2004 | CN1162543C Gene encoding sulfotransferase |
| 08/18/2004 | CN1162443C Cellular injury response element and uses thereof |
| 08/18/2004 | CN1162185C Application of matrix metalloprotease tissue inhibitor in preparing medicine for preventing and treating arthritis |
| 08/17/2004 | US6777546 Expression vector for use in the treatment of defects of immunological response |
| 08/17/2004 | US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 08/17/2004 | US6777534 Use of those antagonists in the treatment of disorders that are associated with vascular endothelial growth factor (vegf) |
| 08/17/2004 | US6777439 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 08/17/2004 | US6777388 Correcting energy imbalance responsible for obese phenotype; utilizes amino acid sequences 2 and 18; homeostasis of body weight and adipose tissue mass |
| 08/17/2004 | US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex |
| 08/17/2004 | US6777233 Cell culture of nervous system cells |
| 08/17/2004 | US6777231 Adipose-derived stem cells and lattices |
| 08/17/2004 | US6777217 Genes which are involved in the control of chromatin structure and, thus in transcription and translation; used to control cell proliferation and differentiation in vitro and in vivo |
| 08/17/2004 | US6777203 Telomerase promoter driving expression of therapeutic gene sequences |
| 08/17/2004 | US6777192 Contacting the sample with an isolated recombinant immunodominant neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex |
| 08/17/2004 | US6777179 Drug screening for an antiviral agent, viricides; genetic engineering |
| 08/17/2004 | US6776987 Enhancement of cardiac chronotropy |
| 08/17/2004 | US6776986 Nucleic acid sequence which, when generates mrna which anneals with mrna stranscrip from hiv-1 provirus encoding env, pol, and/or gag proteins |
| 08/17/2004 | US6776985 Encapsulated cells producing viral particles |
| 08/17/2004 | US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | CA2295861C Method of preparing a transgenic non-human animal expressing p25 |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/12/2004 | WO2004067753A2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 08/12/2004 | WO2004067751A1 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 08/12/2004 | WO2004067745A1 Gene expression inducing fusion protein and method for controlling gene expression induction |
| 08/12/2004 | WO2004067743A1 Vaccine production using transposon based vectors |
| 08/12/2004 | WO2004067736A2 Custom-made meganuclease and use thereof |
| 08/12/2004 | WO2004067719A2 Growth hormone releasing hormone (ghrh) for use in reducing culling in herd animals |
| 08/12/2004 | WO2004067717A2 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 08/12/2004 | WO2004067710A2 Compositions and methods for tissue specific targeting of lentivirus vectors |
| 08/12/2004 | WO2004067707A2 Administration of transposon-based vectors to reproductive organs |
| 08/12/2004 | WO2004067706A2 Production of multimeric proteins |
| 08/12/2004 | WO2004067701A2 Improved genetic elements providing high levels of expression |
| 08/12/2004 | WO2004067566A1 Factor viii polypeptide |
| 08/12/2004 | WO2004067563A1 Peptide inhibitors of toxins derived from ll-37 |